
Therapies at Cipla
With our growing scientific understanding of rare diseases, we shall continue to introduce ground breaking therapies to give our patients their new beginnings!
From Care to Cure
Employee stories
Hear it from the Cipla-ites!

Nada Nehme
Country Manager, Lebanon
Investor Centre
Stock Price Index
Note: The displayed data is not in real time and may have streaming delays.
Turnover
$2.3 Billion
Latest Press Releases
Investor Resources
.@SaminaHamied shares 'The pharmaceutical industry needs to partner with technology and other players. This will help us provide better and more rounded services to users' during the CEO panel discussion. @Cipla_Global #IPF2021 #PatientCentricity #QualityManagement #IPA
'It was exceptional to collaborate with industry and government during #COVID19'- Ms. @SaminaHamied, Executive Vice Chairperson, @Cipla_Global. #IPF2021 #PatientCentricity #QualityManagement #IPA

The most awaited CEO panel discussion on 'COVID-19 impact on Pharmaceutical Industry' begins with Mr. Gautam Kumra - Managing Partner, @McKinseyIndia moderating the session. #IPF2021 #PatientCentricity #QualityManagement #IPA https://t.co/psq8ms3HmC
Break-up with Cigarette today. Quit smoking with Nicotex gums and patches. #WeBelieveYouCan #stayhealthy #quitsmoking https://t.co/ITNbkaxA7o